Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Early Amazon Prime Day 2021 deals: Instant Pots, Roku, and AirPods – Business Insider
Article feature image
Former SEC chair on the market risks even meme stock traders can’t afford to ignore – CNBC
Article feature image
Subway tuna remains a mystery: NYT – Business Insider